Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases
- 8 August 2002
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 33 (7) , 1010-1019
- https://doi.org/10.1016/s0891-5849(02)00993-0
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Myeloperoxidase, a Leukocyte-Derived Vascular NO OxidaseScience, 2002
- Cyclophosphamide Decreases Nitrotyrosine Formation and Inhibits Nitric Oxide Production by Alveolar Macrophages in MycoplasmosisInfection and Immunity, 2001
- l-Arginine Chlorination Products Inhibit Endothelial Nitric Oxide ProductionPublished by Elsevier ,2001
- Increased atherosclerosis in myeloperoxidase-deficient miceJournal of Clinical Investigation, 2001
- Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitisThe Journal of Heart and Lung Transplantation, 2000
- FibronectinArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuliBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemiaJournal of the American College of Cardiology, 1996
- Properties of circulating leukocytes in spontaneously hypertensive ratsBiochemistry and Cell Biology, 1995
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994